Following the validation of the genes identified in the genome‐wide CRISPR screen in hESCs, CCLs, and mice models, it becomes apparent that EXO1, NR5A2, and PLK2 may demonstrate synthetic lethality with MMR deficiency. This evidence concerns the gene PLK2 and mismatch repair cancer syndrome 1.